LeMaitre Vascular, Inc. Financials

Market Capitalization $2.18 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	53.24
Forward PE	44.65
Price to Sales TTM	$10.23
Price to Book MRQ	$6.58
Enterprise to Revenue	9.73
Enterprise to EBITDA	34.99

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	19.40%
Operating Margin	23.98%
Return on Assets TTM	8.72%
Return on Equity TTM	13.33%

Income Statement

Revenue TTM	$213,028,992
Revenue per Share TTM	$9.51
Quarterly Revenue Growth	15.60%
Gross Profit TTM	$145,576,000
EBITDA	$60,979,000
Net Income to Common TTM	$41,319,000
Diluted EPS TTM	$1.82
Quarterly Earnings Growth YoY	48.50%

Balance Sheet

Total Cash MRQ	$123,889,000
Total Cash per Share MRQ	$5.51
Total Debt MRQ	$
Total Debt to Equity MRQ	5.54
Current Ratio MRQ	7.74
Book Value per Share MRQ	$14.73

Cash Flow

Operating Cash Flow TTM	$39,688,000
Levered Free Cash Flow TTM	$22,955,000

LMAT Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	22,484,000
Float Shares	20,504,977
Avg 10 Volume	124,640
Avg 30 Volume	None
Shares Short	1,212,754
Short Ratio	5.71
Short % of Shares	7.18%
% Held by Insiders	8.88%
% Held by Institutions	93.08%

Stock Price Summary

Beta	0.89
Fifty Two Week Low	$56.04
Fifty Two Week High	$109.58
Fifty Two Week Change	39.91%
Day 50 MA	$98.58
Day 200 MA	$86.87

Dividends and Splits

Forward Annual Dividend Rate	$0.64
Forward Annual Dividend Yield	0.66%
Trailing Annual Dividend Rate	$0.64
Trailing Annual Dividend Yield	0.66%
Payout Ratio	34.07%
Dividend Date	2024-12-05
Ex Dividend Date	2024-11-21
Last Split Factor
Last Split Date